

DIRECTOR DEALINGS: Tiziana Life Says Associate Of Chair Bought Shares


Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda


Tiziana Says Antibody Foralumab "Well Tolerated" At All Doses Tested


(Sharecast News) - Clinical-stage biotechnology company Tiziana Life Sciences announced the initiation of a phase 1 clinical trial in healthy voluntee...


Tiziana Life Sciences Kicks Off Oral Trials Of Antibody Foralumab


Tiziana Life Sciences Settles Fee; Director Zambeletti Departs


Tiziana Life Sciences Issues GBP1.4 Million Convertible Loan Notes


Tiziana Loss Narrows In "Busy" First Half, Looks To Advance Drug Tests